Adam Bagg

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Attending in Hematopathology, Laboratory Hematology, Flow Cytometry and Molecular Pathology, Hospital of the University of Pennsylvania
Director, Hematology, Hospital of the University of Pennsylvania
Interim Director, Hematopathology , Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine

Contact information
Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
7.103 Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-4280
Fax: 215-662-7529
Education:
MB. BCh (magna cum laude)
University of the Witwatersrand, South Africa, Top 1% of graduating class, 1981.
Permanent link
 

Description of Research Expertise

Molecular genetics and pathology of Leukemias and Lymphomas; Myelodysplastic syndromes; Minimal residual disease; Hodgkin lymphoma

Description of Itmat Expertise

Dr. Bagg studies: (1) the diagnostic molecular pathology of hematologic malignancies, with the development of novel assays to facilitate their diagnosis; (2) minimal residual disease testing in leukemia, lymphoma and myeloma; and (3) unraveling the biology and improving the laboratory diagnosis of the myelodysplastic syndromes.

Selected Publications

Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, Weinzierl E, Hatem J, Jaso J, Kanagal-Shamanna R, Stingo FC, Patel KP, Mehrotra M, Bueso-Ramos C, Young KH, Dinardo CD, Verstovsek S, Tiu RV, Bagg A, Hsi ED, Arber DA, Foucar K, Luthra R, Orazi A: Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 123(17), Apr 2014

Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JJ, Bagg A, Liu YC, Mathew S, Orazi A, Lin P, Wang SA, Bueso-Ramos CE, Foucar K, Hasserjian RP, Tiu RV, Karafa M, Hsi ED. : Complex or monosomal karyotype and not blast percentage are associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica 99(5): 821-9, May 2014.

Raess PW, van de Geijn GJ, Njo TL, Klop B, Sukhachev D, Wertheim G, McAleer T, Master SR, Bagg A.: Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters. Am J Hematol 89(4): 369-74, Apr 2014.

Nybakken G, Bagg A. : The Genetic Basis and Expanding Role of Molecular Analysis in the Diagnosis, Prognosis and Therapeutic Design in Myelodysplatic Syndromes. J Mol Diagn 16(2): 145-58, Mar 2014.

Wertheim GBW, Smith C, Figeroa ME, Kalos M, Bagg A, Carroll M, Master SR.: Microsphere-based Multiplex Analysis of DNA Methylation in Acute Myeloid Leukemia. J Mol Diagn 16(2): 207-15, Mar 2014.

King RL, Howard MT, Bagg A: Hodgkin Lymphoma: Pathology, Pathogenesis, and a Plethora of Potential Prognostic Predictors. Adv Anat Pathol 21(1), Jan 2014.

King RL, Bagg A. : Genetics of Diffuse Large B-cell Lymphoma: Paving a Path to Personalized Medicine. Cancer J 20(1): 43-7, Jan-Feb 2014.

Linette GP, Stadtmauer EA, Maus MV, Rapoport AP, Levine BL, Emery L, Litzky L, Bagg A, Carreno BM, Cimino PJ, Binder-Scholl GK, Smethurst DP, Gerry AB, Pumphrey NJ, Bennett AD, Brewer JE, Dukes J, Harper J, Tayton-Martin HK, Jakobsen BK, Hassan NJ, Kalos M, June CH.: Cardiovascular toxicity and titin cross-reactivity of affinity enhanced T cells in myeloma and melanoma. Blood 122(6), Jun 2013

Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJ, Daber R, Bagg A.: BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia. Blood 122(17): 3084-5, Oct 2013.

Bagg A, and Dunphy CH.: Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders. Semin Diagn Pathol 30(2): 102-12, May 2013.

back to top
Last updated: 07/02/2014
The Trustees of the University of Pennsylvania